Assembly Biosciences Inc expected to post a loss of 47 cents a share - Earnings Preview

Assembly Biosciences

31/10/2022 13:51

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show
a fall in quarterly revenue when it reports  results on November
2 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Assembly
Biosciences Inc
is for a loss of 47 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $2.5​, above​ its last closing price
of $1.65. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.48       -0.47      -0.51     Missed  -9.4
 Mar. 31 2022  -0.57       -0.47      -0.48     Missed  -1.1
 Dec. 31 2021  -0.51       -0.48      -0.38     Beat    20.4​
 Sep. 30 2021  -0.55       -0.56      -0.41     Beat    26.6
 ​​Jun.        -0.65       -0.66      -0.55     Beat    16.2
 30 2021                                                
 Mar. 31 2021  -0.78       -0.79      -0.69     Beat    12.2​
 Dec. 31 2020  -0.90       -0.90      -0.96     Missed  -6.2
 Sep. 30 2020  -0.73       -0.75      -0.09     Beat    88
 This summary was machine generated October 31 at 13:51 GMT.  All
figures in US dollars  unless otherwise stated